On April 19, 2022 Teen Cancer America reported the science and excitement behind liquid biopsies, and their potential to change the global paradigm in early cancer detection, will go mainstream for the first time (Press release, Teen Cancer America, APR 19, 2022, View Source [SID1234612514]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The historic S.E.E. Summit (Safer, Easier, Earlier) is a free, virtual event created by cancer survivor/journalist Jamie Reno and Teen Cancer America, the national non-profit founded by Roger Daltrey and Pete Townshend of The Who. The online conference will feature leading biotechnology executives, researchers, oncologists, and patient advocates explaining the game-changing impact of liquid biopsy blood tests in ways that everyone can understand.

Breakthroughs in genomics have accelerated the ability of liquid biopsies to identify biomarkers in the blood that can detect cancer very early. These advancements represent a major milestone for cancer screening, diagnosis and treatment as a non-invasive alternative to tissue biopsy.

Produced by The Special Event Company, the summit will include pre-recorded segments featuring preeminent liquid biopsy experts from Caris Life Sciences, Exact Sciences/Thrive, Grail, Guardant, IV BioHoldings (IVBH), Natera, Pillar Biosciences and StageZero Life Sciences. The recorded presentations will alternate with two live panel discussions that will include leading scientists, oncologists, patients and patient advocates.

The event takes place on Thursday, April 21 beginning at 12 p.m. ET, 9 a.m. PT. Online attendance is free, and registration is available at this LINK. S.E.E. Summit run-of-show:

9:00 – Welcome

Simon Davies – Executive Director, Teen Cancer America
Jamie Reno – Healthline journalist, author, cancer survivor and advocate
9:10 – IV BioHoldings

Marty Keiser – Founder & CEO
9:25 – Natera

Dina Scaglione – Director Oncology Marketing
Adham Jurdi MD – Medical Director
9:40 – Grail

Joshua Ofman MD – President and Chief Medical Officer
9:55 – Panel #1 – Advocates

Hilary Gan – Hospital Programs and Services Director, Teen Cancer America (breast cancer survivor)
Christabel K. Cheung, PhD, MSW – Assistant Professor, University of Maryland School of Social Work; Member, University of Maryland Greenbaum Comprehensive Cancer Center; Collaborating Member, University of Hawaii Cancer Center (Non-Hodgkin’s lymphoma cancer survivor)
Judy Fulmer – Prevention Chair, PREP4 Gold (parent of a teen cancer survivor)
10:40 – Guardant

Michele Rest – Senior Director of Corporate Communications
AmirAli Talasaz – Co-founder & Co-CEO
10:55 – StageZero Life Sciences

James Howard-Tripp – Chairman & CEO
11:10 – Caris Life Sciences

Rob Clark – Sr. Vice President, Chief Communications Officer
David Spetzler PhD – President and Chief Scientific Officer
11:25 – Panel #2 – Scientists/Physicians

Jerome Madison – VP Pharma and Provider Relations, Trapelo Health
David Shulman MD – Attending Physician, Pediatric Oncology, Sarcoma Center, Dana-Farber/Boston Children’s Cancer and Blood Disorders Center
Aditya Bagrodia MD, FACS – Urologic Oncologist, Associate Professor of Urology, Disease Team Co-Leader, Genitourinary Cancer, UC San Diego Health
Umberto Malapelle – Secretary of the International Society of Liquid Biopsy; Professor in Anatomic Pathology in School of Medicine, University of Naples Federico
Abhijat Kitchlu MD – Department of Medicine, Division of Nephrology at the University of Toronto
12:10 – Exact Sciences/Thrive

Isaac Kinde, MD, PhD – VP Technology Assessment
12:25 – Pillar Biosciences

Randy Pritchard – CEO
12:40 – Concluding remarks from Jamie Reno and Simon Davies

"This is the first event to bring the science of liquid biopsy out of stealth mode," said Reno. "Our goal is to share information about this growing sector in ways that scientists appreciate but consumers, healthcare professionals, potential investors and the media can also understand."

The organizations participating in the S.E.E. Summit plan to extend the program into a series of educational media initiatives to educate and inform cancer patients, healthcare professionals, and the general public.

"Liquid biopsy is a major step forward in cancer detection among all age groups, but it is especially significant for our work at TCA," said Davies. "Late detection and misdiagnosis are not uncommon for teens and young adults with cancer, so we’re thrilled to help bring this good news to mainstream audiences for the first time."